Prospera Financial Services competitors

Murray has worked as Chief Executive Officer at CONVERGENT; Interim Chief Executive Officer at GWG HOLDINGS, INC.; and Managing Director at MHT Partners. He studied at University of Virginia and Washington and Lee University.

William Greenberg is a Chief Executive Officer at Two Harbors Investment and Managing Director at Two Harbors Investment and is based in New, York. He has worked as Co-Chief Investment Officer at Two Harbors Investment, Postdoctoral Research Associate at University of Pennsylvania, and Managing Director at UBS. William studied at University of Washington between 1989 and 1993 and Massachusetts Institute of Technology (MIT) between 1985 and 1989.

Tadayoshi Yamaguchi joined ITOCHU Corporation in April 1989. In April 2020, he assumed the role of Senior Vice President, Chief Administrative Office and General Manager of the Corporate Planning Division, ITOCHU International Inc. and President & CEO, ITOCHU Canada Ltd.

Jay Grossman joined Abry in 1996. Jay is the co-CEO of Abry. He has originated, supervised and sold numerous companies in Abry’s targeted sectors. Areas of focus have included cable television, communications, data centers and business services. Prior to joining Abry Jay was Managing Director and co-head of the Media and Entertainment Group at Prudential Securities, Inc. Previously, he was a member of the corporate finance department of Kidder, Peabody & Company, specializing primarily in media and entertainment companies. Jay received an MBA from Harvard Business School and is an honors graduate of Dickinson College.

Mr. Stephen E. Budorick is an Executive Vice President and Chief Operating Officer at CORPORATE OFFICE PROPERTIES TRUST and is based in United States.

An entrepreneurial executive specializing in growth strategies. Managing, motivating and coaching people toward a common business goal is a core strength. Experience includes Board of Directors, IPO, M&A, Sales, Business Development, Marketing and Operations. Expertise in start-ups to Fortune 6 environments.Applied growth strategies within the following market segments:In Vitro Diagnostics, Instrument Development, Single-Use bioreactors, Gene Expression Analysis, GMP services, Filtration, Cell Culture, Microscopy, Protein Crystallography, Liquid Chromatography, DNA/RNA chemistry, Peptide chemistry, Biologics, Biosimilars and Drug Development.